AdminJun 10, 20172 min readHigh Take-Two Cure Rates With Gilead’s New Triple-Drug Hep C RegimenThe fixed-dose combination tablet sofosbuvir/velpatasvir/voxilaprevir provides a good alternative to those who have failed treatment....
